Adverse event totals18

The totals the trial posted for each group.

1 to 18 of 18

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo
Total, all-cause mortality	Pregabalin 50 mg
Total, all-cause mortality	Pregabalin 100 mg
Total, all-cause mortality	Pregabalin 150 mg
Total, all-cause mortality	Pregabalin 300 mg
Total, all-cause mortality	Pregabalin 450 mg
Total, other adverse events	Placebo	13	23
Total, other adverse events	Pregabalin 50 mg	9	22
Total, other adverse events	Pregabalin 100 mg	12	23
Total, other adverse events	Pregabalin 150 mg	15	22
Total, other adverse events	Pregabalin 300 mg	17	24
Total, other adverse events	Pregabalin 450 mg	19	23
Total, serious adverse events	Placebo	0	23
Total, serious adverse events	Pregabalin 50 mg	1	22
Total, serious adverse events	Pregabalin 100 mg	0	23
Total, serious adverse events	Pregabalin 150 mg	0	22
Total, serious adverse events	Pregabalin 300 mg	0	24
Total, serious adverse events	Pregabalin 450 mg	0	23

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00676403/event-totals